Rudolph, Tanja K. http://orcid.org/0000-0001-8839-7476
Herrmann, Eva
Bon, Dimitria
Walther, Thomas
Bauer, Timm
Ensminger, Stephan
Frerker, Christian
Beckmann, Andreas
Möllmann, Helge
Bekeredjian, Raffi
Beyersdorf, Friedhelm
Hamm, Christian
Baldus, Stephan
Böning, Andreas
Gummert, Jan
Rudolph, Volker
Bleiziffer, Sabine
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung
Boston Scientific Corporation
Dr. Rolf M. Schwiete Stiftung
Edwards Lifesciences
Medtronic Europe
Abbott Fund
Ruhr-Universität Bochum
Article History
Received: 25 January 2023
Accepted: 2 June 2023
First Online: 18 July 2023
Declarations
:
: T. Rudolph is a proctor for Edwards Lifesciences and Boston Scientific and received speaker´s honoraria from Edwards Lifesciences, Medtronic, Abbott and Boston Scientific/Symetis SA. S. Ensminger is a consultant for Edwards LifeSciences and received speaker’s honoraria from Edwards LifeSciences and Medtronic. <i>C. Frerker</i> received speaker’s honoraria and travel support from Edwards Lifesciences, Medtronic, Boston Scientific, Abbott Vascular, Biotronik. H. Möllmann received speaker ‘s honoraria and / or consulting fees from Abbott, Boston Scientific, Edwards Lifesciences, and SMT. C. Hamm is an Advisory Board member of Medtronic. S. Baldus has received a research grant from Abbott and lecture fees from Abbott and Edwards. A. Böning has received speaker’s honoraria/consulting fees from Abiomed, Bayer, Edwards Lifesciences, Orion Pharma, Maquet, Smith & Nephew, Somahlution, Resuscitec, and Zoll, and is Advisory Board Member of Nordic Pharma and Guard Therapeutics. V. Rudolph has received research grants from Abbott Vascular and Edwards Lifesciences. S. Bleiziffer is a proctor for Medtronic and received speaker´s honoraria from Medtronic, Abbott, and Boston Scientific. E. Herrmann, D. Bon, T. Walther, T. Bauer, A. Beckmann, R. Bekeredijan, F. Beyersdorf, J. Gummert on have nothing to disclose.